Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.38.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.38.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N/ANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N/ANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N/ANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
B.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-1981.37China
B.1.494NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.494NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.494NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.167NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.167NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.167NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.267NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.267NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.267NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.165NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.165NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.554NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.554NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.554NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.243.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.450NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.450NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.130NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.130NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.444NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.444NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.444NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
AW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used